Evidence map›Paper›PMID 30214253›Full record

ArticleInfection and drug resistance2018

Prevalence of

Dominique Fatima Voumbo-Matoumona, Lady Charlène Kouna, Marylin Madamet, Sydney Maghendji-Nzondo, Bruno Pradines, Jean Bernard Lekana-Douki

Abstract read
In one paragraph

Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Polymorphism ofJournal of parasitology research · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Drug Resistance Molecular Markers ofTropical medicine and infectious disease · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Limited Polymorphism inInfection and drug resistance · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dominique Fatima Voumbo-MatoumonaUnit of Evolution, Epidemiology and Parasitic Resistances (UNEEREP), International Medical Research Center of Franceville (CIRMF), Franceville, Gabon, lekana_jb@yahoo.fr.
Lady Charlène KounaDepartment of Parasitology, Mycology and Tropical Medicine, University of Health Sciences, Libreville, Gabon, lekana_jb@yahoo.fr.
Marylin MadametParasitology and Entomology Unit, Department of Infectious Diseases, Biomedical Research Institute of Army, Marseille, France.
Sydney Maghendji-NzondoDepartment of Parasitology, Mycology and Tropical Medicine, University of Health Sciences, Libreville, Gabon, lekana_jb@yahoo.fr.
Bruno PradinesParasitology and Entomology Unit, Department of Infectious Diseases, Biomedical Research Institute of Army, Marseille, France.
Jean Bernard Lekana-DoukiUnit of Evolution, Epidemiology and Parasitic Resistances (UNEEREP), International Medical Research Center of Franceville (CIRMF), Franceville, Gabon, lekana_jb@yahoo.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe introduction of artemisinin-based combination therapies (ACTs) in treating uncomplicated malaria and sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment during pregnancy drastically decreased the burden of malarial disease around the world. However, ACTs are known to select for drug resistance markers. In Gabon, artemether-lumefantrine induced an increase in the prevalence of N86-

methodsA total of 233

resultsThe overall prevalence (3.7%-11.5%) of the wild-type haplotype

conclusionDespite the withdrawal of chloroquine, the frequency of the resistant allele 76T remained high in the south of Gabon. Moreover, a high level of resistant haplotypes against IPTp-SP was found.

Indexed as

antimalarial drug resistanceGabonPfcrtPfdhfr/PfdhpsPfK13Plasmodium falciparum

Identifiers

PMID30214253
PMCPMC6118251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.